InvestorsHub Logo
Followers 66
Posts 12687
Boards Moderated 0
Alias Born 06/03/2015

Re: Investor2014 post# 448729

Monday, 01/22/2024 9:27:32 AM

Monday, January 22, 2024 9:27:32 AM

Post# of 459685
As I recall, the trial size decision was based on the recommendation of a highly qualified outside consultant after reviewing the AVATAR data. Nonetheless, don't you think that RAs would be quite curious to understand the reasons behind the difference in placebo results between the trofinetide trial (1.7-pt improvement) vs the Excellence trial (8.3-pt improvement)... as well as the comparison between trofinetide treatment (4.9-pt improvement) vs blarcamesine treatment (12.9-pt improvement)? No doubt they will.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News